Psycheceutical Bioscience Eulerpool News

Psycheceutical Bioscience Eulerpool-AFX

Psycheceutical Bioscience Stock News

Psycheceutical Bioscience is being monitored by journalists and investors worldwide. We gather the latest Psycheceutical Bioscience news here.

• May 16 ·

  Yahoo
  Historical Regulatory Filing Deficiences Continue to Stifle Psycheceutical Biosciences
• January 17 ·

  Yahoo
  Psycheceutical Bioscience Strategically Pivots Into the Brain-Computer Interface (BCI) Space
• December 12 ·

  Yahoo
  Dr. Neilank Jha Appointed as Executive Chairman and Chief Executive Officer of Psycheceutical Bioscience Inc.
• November 1 ·

  Yahoo
  Psycheceutical Bioscience Launches Wefunder Crowdfunding Campaign for Safer Psychedelic Dosing
• August 10 ·

  Yahoo
  Psycheceutical Announces Successful First Cohort Dosing; Moves to Dose Escalation in Phase I Trial of NeuroDirect Ketamine for PTSD
• August 1 ·

  Yahoo
  Psycheceutical Bioscience Announces Completion of PCAOB Audit and Future Corporation Action Strategy
• July 13 ·

  Yahoo
  First Patient Dosed in Psycheceutical's Phase I Study Exploring Topical Administration of Ketamine to Treat PTSD
• April 18 ·

  Yahoo
  The Next Generation Of Mental Health Treatment: Psycheceutical Bioscience Inc.’s (OTCPK:BWVI) Novel Topical Ketamine Delivery
• April 13 ·

  Yahoo
  Psycheceutical Bioscience, Inc. Named a 2023 Top 10 Biotech Startup by Life Sciences Review
• April 9 ·

  Nasdaq
  Weekly Preview: Earnings to Watch This Week 4-9-23 (C, DAL, JPM, TLRY)